IAC Express 2006 |
|
Issue number 265: October 16, 2006 |
|
|
|
Contents
of this Issue
(Select a title to
jump to the article.) |
- New: CDC releases October
2006-September 2007 adult
immunization schedule
- New: Interim VIS for HPV
vaccine in Spanish; VISs for
injectable and nasal-spray
influenza vaccines in Armenian
- October issue of CDC's
Immunization Works electronic newsletter now available on the NIP website
- National Influenza Vaccine
Summit posts its August-September newsletter
- New: The October 2006
issue of Vaccinate Adults is in the
mail and on the Web
- AAP publishes three
articles on measles-containing vaccine
- CDC launches multi-state
study to identify risk factors for
autism-spectrum disorders,
awards $5.9 million
- What's your state doing?
PandemicFlu website posts comprehensive array of state pandemic planning
information
- New state requirements:
Governors of Kansas, Louisiana, and New York sign immunization legislation
- CDC publishes update on
vaccine-derived polioviruses worldwide
- MMWR issues correction to
its October 6 report on 2004-05 childhood influenza vaccination coverage
|
| |
| Abbreviations |
|
|
AAFP, American Academy
of Family Physicians; AAP, American Academy of Pediatrics; ACIP, Advisory Committee on Immunization Practices; CDC, Centers for Disease Control
and Prevention; FDA, Food and Drug Administration; IAC, Immunization
Action Coalition; MMWR, Morbidity and Mortality Weekly Report; NIP, National
Immunization Program; VIS, Vaccine Information Statement; VPD, vaccine-preventable disease; WHO, World Health Organization. |
| |
| Issue 625: October
16, 2006 |
|
|
|
1. |
October 16, 2006
NEW: CDC RELEASES OCTOBER 2006-SEPTEMBER 2007 ADULT IMMUNIZATION
SCHEDULE
CDC published "Recommended Adult Immunization Schedule—United States, October
2006-September 2007" as an MMWR QuickGuide in the October 13 issue of MMWR.
The article is reprinted below in its entirety, excluding references and two
figures.
***********************
The Advisory Committee on Immunization Practices (ACIP) annually reviews the
recommended Adult Immunization Schedule to ensure that the schedule reflects
current recommendations for the licensed vaccines. In June 2006, ACIP
approved the Adult Immunization Schedule for October 2006-September 2007.
This schedule has also been approved by the American Academy of Family
Physicians and the American College of Obstetricians and Gynecologists.
CHANGES IN THE SCHEDULE FOR OCTOBER 2006-SEPTEMBER 2007
The 2006-2007 schedule differs from the previous schedule as follows:
- The broken red line has been deleted on the
age-based schedule. Vaccination of persons with specific risk factors is
now shown only with purple bars.
- Human papillomavirus (HPV) vaccine has been
added to the age-based schedule, with a yellow bar indicating that the
vaccine is recommended for women <=26 years.
- Tetanus, diphtheria, and acellular
pertussis (Tdap) vaccine has been added to the age-based schedule, with a
hatched yellow bar indicating that Tdap is a one-time, 1-dose
recommendation for persons <=64 years.
- The purple bar for varicella vaccine has
been shortened in anticipation of the recommendation for the use of zoster
vaccine in persons aged >=60 years.
- A new column has been added to the
medical/other indications schedule to clarify indications for hepatitis A
and B vaccines. The indications "chronic liver disease" and "recipients of
clotting factor concentrates" have been removed from the previous
schedule's third and fifth columns, respectively, and combined into a new
column. The column has a yellow bar for hepatitis A and B vaccines,
clarifying that these vaccines are recommended for all persons with these
medical indications.
- HPV vaccine has been added to the
medical/other indications schedule, with a yellow bar to indicate the
vaccine is recommended for women aged <=26 years with all indications
except pregnancy.
- Tdap was added to the medical/other
indications schedule, with a hatched yellow bar to indicate that Tdap is a
one-time, 1-dose recommendation for all indications except pregnancy.
- The tetanus and diphtheria footnote (#1)
has been reworded to reflect ACIP recommendations for use of Tdap.
- A footnote (#2) has been added to reflect
ACIP recommendations for HPV vaccination for all women aged <=26 years.
- The measles, mumps, and rubella (MMR)
footnote (#3) has been reworded to reflect ACIP recommendations to
administer a second dose of mumps vaccine to adults in certain age groups
and with certain risk factors.
- The varicella footnote (#4) has been
reworded in accordance with ACIP recommendations for administering a
routine second dose for all adults without evidence of immunity. The
footnote also has been revised to reflect the new definition of immunity to
varicella.
- The influenza footnote (#5) has been
revised to reflect recent ACIP recommendations to vaccinate close contacts
of children aged 0-59 months rather than 0-23 months.
- The hepatitis B footnote (#9) has been
revised to reflect recommendations to vaccinate any adult seeking
protection from hepatitis B virus infection and vaccinate adults in
specific settings (e.g., sexually transmitted disease clinics).
The Adult Immunization Schedule is available
in English and Spanish at
http://www.cdc.gov/nip/recs/adult-schedule.htm [IAC Express editor's
note: the Spanish-language version will be available in January 2007].
General information about adult vaccinations, including recommendations
concerning vaccination of person with HIV and other immunosuppressive
conditions, is available from state and local health departments and at
http://www.cdc.gov/nip Vaccine
information statements are available at
http://www.cdc.gov/nip/publications/vis ACIP statements for each
recommended vaccine and provisional vaccine recommendations can be viewed,
downloaded, and printed at
http://www.cdc.gov/nip/publications/acip-list.htm Instructions for
reporting adverse events to the Vaccine Adverse Event Reporting System are
available at http://www.vaers.hhs.gov
or by telephone, (800) 822-7967.
***********************
To access a web-text (HTML) version of the complete article, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5540a10.htm
To access a ready-to-print (PDF) version of this MMWR issue, go to:
http://www.cdc.gov/mmwr/PDF/wk/mm5540.pdf
To receive a FREE electronic subscription to MMWR (which includes new ACIP
statements), go to:
http://www.cdc.gov/mmwr/mmwrsubscribe.html
Back to
top |
| |
|
|
2. |
October 16, 2006
NEW: INTERIM VIS FOR HPV VACCINE IN SPANISH; VISs FOR INJECTABLE AND
NASAL-SPRAY INFLUENZA VACCINES IN ARMENIAN
The current interim VIS for human papillomavirus (HPV) vaccine (dated 9/5/06)
is now available in Spanish. Dated 6/30/06, the current VISs for trivalent
inactivated influenza vaccine (TIV) and live attenuated intranasal influenza
vaccine (LAIV) are available in Armenian. IAC gratefully acknowledges the
California Department of Health Services for the translations.
INTERIM HPV VACCINE VIS (dated 9/5/06)
To obtain a ready-to-print (PDF) version of the VIS for HPV vaccine in
Spanish, go to:
http://www.immunize.org/vis/sp_hpv.pdf
To obtain it in English, go to:
http://www.immunize.org/vis/vis-hpv-gardasil.pdf
INFLUENZA VACCINE VISs (dated 6/30/06)
To obtain a ready-to-print (PDF) version of the VIS for TIV in Armenian, go
to:
http://www.immunize.org/vis/ar_flu06.pdf
To obtain it in English, go to:
http://www.immunize.org/vis/2flu.pdf
To obtain a ready-to-print (PDF) version of the VIS for LAIV in Armenian, go
to:
http://www.immunize.org/vis/arLAIV06.pdf
To obtain it in English, go to:
http://www.immunize.org/vis/liveflu.pdf
For information about the use of VISs, and for VISs in more than 30
languages, visit IAC's VIS web section at
http://www.immunize.org/vis
Back to
top |
| |
|
|
3. |
October 16, 2006
OCTOBER ISSUE OF CDC'S IMMUNIZATION WORKS ELECTRONIC NEWSLETTER NOW AVAILABLE
ON THE NIP WEBSITE
The October issue of Immunization Works, a monthly email newsletter published
by CDC, is available on NIP's website. The newsletter offers members of the
immunization community non-proprietary information about current topics. CDC
encourages its wide dissemination.
Some of the information in the October issue has already appeared in previous
issues of IAC Express. Following is the text of three articles we have not
covered.
***********************
FDA APPROVES ADDITIONAL INFLUENZA VACCINE
The U.S. Food and Drug Administration (FDA) approved FluLaval, an influenza
vaccine to immunize people 18 years of age and older against the disease
caused by strains of influenza virus judged likely to cause seasonal flu in
the Northern Hemisphere in 2006-2007.
With this additional vaccine, CDC projects a total of about 115 million doses
of influenza vaccine for the 2006–2007 season, but these projections could
change as manufacturing continues. Furthermore, 75 million doses are
projected for distribution by October 31st.
FluLaval was approved using FDA's accelerated approval pathway, which allows
the agency to approve products for serious or life-threatening diseases based
on early evidence of a product's effectiveness, reducing the time it takes
for needed medical products to become available to the public. In this case,
the manufacturer demonstrated that the vaccine induced levels of antibodies
in the blood likely to be effective in preventing seasonal influenza. As part
of the accelerated approval process, the manufacturer will conduct further
studies to verify that the vaccine will decrease seasonal influenza disease
after vaccination. FluLaval is the second seasonal influenza vaccine approved
using the accelerated approval process; GlaxoSmithKline's Fluarix received
approval in 2005. To view the complete FDA press release on FluLaval, please
visit
http://www.fda.gov/bbs/topics/NEWS/2006/NEW01478.html
CDC encourages anyone who wants to be protected against influenza to seek
vaccination, especially those at increased risk for influenza-related
complications as well as those who live with or care for people at high
risk—including healthcare providers, children between 6 months and up to 5
years old, and people with chronic diseases such as diabetes, asthma, and
heart disease, as well as people 50 years old and older. For the 2006-07
season, CDC projects that vaccine supplies will be adequate for children ages
6-23 months. There is also likely to be sufficient influenza vaccine for
4-year-olds. Vaccine doses licensed for 3-year-olds, however, are limited in
supply, and CDC anticipates that there will be insufficient vaccine for this
age group. More information about influenza and influenza vaccine can be
found at http://www.cdc.gov/flu and
CDC's Flu Gallery can be found at
http://www.cdc.gov/flu/gallery
************************
MEETINGS, CONFERENCES & RESOURCES
IMMUNIZATION PROVIDER AWARDS ANNOUNCED: CDC awarded five cooperative
agreements to immunization provider organizations. Approximately $140,000
will be awarded to each of five organizations: American Academy of Family
Physicians (AAFP), American College of Obstetricians and Gynecologists (ACOG),
American College of Physicians (ACP), American Pharmacists Association (APhA),
and Interamerican College of Physicians and Surgeons. The new funding will
support a range of new and continuing projects that inform and educate
immunization providers about immunization issues, and promote the improvement
of immunization coverage. Funding for this cooperative agreement is
expected to be available for three years, concluding in September 2009.
Information about future CDC funding opportunities can be found on
http://www.grants.gov
************************
JOIN IZTA: Local or state immunization coalition members are encouraged to
join the Immunization Coalitions National Technical Assistance Network (IZTA).
This CDC-funded project provides free technical assistance and resources to
immunization coalitions across the country, including monthly presentations
on hot immunization topics (via conference call); free individual technical
assistance; access to information about coalition building, social marketing,
evaluation, and other topics; opportunities to share ideas and experiences
with other coalitions across the country; and bi-weekly updates on IZTA
events and immunization news. IZTA is managed by the Academy for Educational
Development (AED). To sign up, please visit
http://www.izcoalitionsta.org
************************
To access the complete October issue from the NIP website, go to:
http://www.cdc.gov/nip/news/newsltrs/imwrks/2006/200610.htm
Back to
top |
| |
|
|
4. |
October 16, 2006
NATIONAL INFLUENZA VACCINE SUMMIT POSTS ITS AUGUST-SEPTEMBER
NEWSLETTER
The National Influenza Vaccine Summit has posted its August-September 2006 newsletter online at
http://www.ama-assn.org/ama1/pub/upload/mm/36/summitnewsletter3_06.pdf
The National Influenza Vaccine Summit website is sponsored by
CDC and the American Medical Association. In addition to its
newsletter, the site includes presentations from meetings and
information about influenza vaccine manufacturing, supply, and
distribution.
To visit the National Influenza Vaccine Summit website, go to:
http://www.ama-assn.org/ama/pub/category/13732.html
Back to
top |
| |
|
|
5. |
October 16, 2006
NEW: THE OCTOBER 2006 ISSUE OF VACCINATE ADULTS IS IN THE MAIL AND ON THE WEB
IAC recently mailed the latest issue of Vaccinate Adults (October 2006) to
145,000 adult medicine specialists and others who work in the field of
immunization. Packed with immunization resources for health professionals and
patients, the 16-page issue is well worth downloading. All articles and
education pieces, except editorials, have been thoroughly reviewed by
immunization and hepatitis experts at CDC.
HOW TO READ VACCINATE ADULTS ON THE WEB
You can view selected articles from the table of contents below or download
the entire issue from the Web.
To view the table of contents with links to individual articles, go to:
http://www.immunize.org/va
The PDF file of the entire issue, linked below, is 1.11 megabytes. For tips
on downloading and printing PDF files, go to:
http://www.immunize.org/nslt.d/tips.htm
To download a ready-to-print (PDF) version of the October issue, go to:
http://www.immunize.org/va/va18.pdf
Below are descriptions of articles published in the October issue, followed
by links:
GENERAL IMMUNIZATION INFORMATION (three resources)
(1) In "Ask the experts," immunization and hepatitis experts from CDC answer
questions about vaccines and their recommended use.
To access a ready-to-print (PDF) version, go to:
http://www.immunize.org/va/va18exprt.pdf
To access a web-text (HTML) version, go to:
http://www.immunize.org/va/va18exprt.htm
(2) "Vaccine highlights" presents information on recently published ACIP
recommendations and newly licensed vaccines.
To access a ready-to-print (PDF) version, go to:
http://www.immunize.org/va/va18info.pdf
(3) "If you administer vaccines, you need these materials" offers four
resources: three patient screening questionnaires and one guideline for
administering intramuscular and subcutaneous injections to persons across the
life span. All can be downloaded.
To access a ready-to-print (PDF) version, go to: http://www.immunize.org/va/adminvacs.pdf
VIRAL HEPATITIS INFORMATION (one resource)
(1) Updated in August, "Hepatitis B and the healthcare worker" is a
comprehensive, three-page Q&A about indications for healthcare worker
hepatitis B vaccination, postvaccination serologic testing, and prophylaxis
after occupational exposure to hepatitis B virus infection.
To access a ready-to-print (PDF) version, go to:
http://www.immunize.org/catg.d/2109hcw.pdf
To access a web-text (HTML) version, go to:
http://www.immunize.org/catg.d/2109hcw.htm
ADULT IMMUNIZATION RESOURCES (one resource)
(1) The three-page chart "Summary of Recommendations for Adult Immunization"
was updated in September with new information on using Td/Tdap vaccines
during pregnancy and on new definitions of evidence of immunity to varicella.
To access a ready-to-print (PDF) version, go to:
http://www.immunize.org/catg.d/p2011b.pdf
To access a web-text (HTML) version, go to:
http://www.immunize.org/catg.d/p2011b.htm
INFLUENZA IMMUNIZATION RESOURCES (two resources)
(1) Completely revised in September, "First do no harm: Protect patients by
making sure all staff receive yearly influenza vaccine!" briefly reviews the
sweeping changes found in the new ACIP recommendations for influenza
vaccination of healthcare personnel and the new standard of the Joint
Commission on Accreditation of Healthcare Organizations (JCAHO).
To access a ready-to-print (PDF) version, go to:
http://www.immunize.org/catg.d/p2014.pdf
To access a web-text (HTML) version, go to:
http://www.immunize.org/catg.d/p2014.htm
(2) "Influenza vaccination standing orders and screening questionnaires"
presents five resources: one sheet of information outlining which persons
need influenza vaccine; one standing orders protocol for administering
influenza vaccine to adults; two patient-screening questionnaires, one for
injectable influenza vaccine and one for intranasal vaccine; and one
Declination of Vaccination form for healthcare employees who decline
influenza vaccination. All can be downloaded.
To access a ready-to-print (PDF) version, go to:
http://www.immunize.org/va/so_screens.pdf
Back to
top |
| |
|
|
6. |
October 16, 2006
AAP PUBLISHES THREE ARTICLES ON MEASLES-CONTAINING VACCINE
In the October 2006 issue of the journal Pediatrics, the American Academy of
Pediatrics published three articles concerning measles-containing vaccines.
Article titles and links to article abstracts or extracts follow; the full
text of articles is available to Pediatrics subscribers.
To access the abstract for "Evaluation of potentially common adverse events
associated with the first and second doses of measles-mumps-rubella vaccine,"
go to:
http://pediatrics.aappublications.org/cgi/content/abstract/118/4/1422
To access the abstract for "No evidence of persisting measles virus in
peripheral blood mononuclear cells from children with autism spectrum
disorder," go to:
http://pediatrics.aappublications.org/cgi/content/abstract/118/4/1664
To access the extract for "Has the measles-mumps-rubella vaccine been fully
exonerated?" go to:
http://pediatrics.aappublications.org/cgi/content/extract/118/4/1744
Back to
top |
| |
|
|
7. |
October 16, 2006
CDC LAUNCHES A MULTI-STATE STUDY TO IDENTIFY RISK FACTORS FOR AUTISM-SPECTRUM
DISORDERS, AWARDS $5.9 MILLION
On October 6, CDC issued a press release announcing it is launching a study
at five sites to identify risk factors for autism-spectrum disorders.
Portions of the press release follow.
*******************
The Centers for Disease Control and Prevention (CDC) is initiating a
multi-state collaborative study to help identify factors that may put
children at risk for autism spectrum disorders (ASDs) and other developmental
disabilities. Approximately 2,700 children, ages 2 to 5, and their parents
will be part of this study.
CDC has awarded a total of $5.9 million to five sites—Kaiser Foundation
Research Institute in California, Colorado Department of Public Health and
Environment, Johns Hopkins University in Maryland, University of North
Carolina at Chapel Hill, and the University of Pennsylvania. These sites make
up the Centers for Autism and Developmental Disabilities Research and
Epidemiology (CADDRE) Network. CDC will also be participating in the study,
and will include children and their parents from the metropolitan Atlanta
area.
"We hope this national study will help us learn more about the
characteristics of children with ASDs, factors associated with developmental
delays, and how genes and the environment may affect child development," said
Dr. Jose F. Cordero, assistant surgeon general and director of CDC's National
Center on Birth Defects and Developmental Disabilities. . . .
*******************
To access the complete press release, go to:
http://www.cdc.gov/od/oc/media/pressrel/r061006.htm
Back to
top |
| |
|
|
8. |
October 16, 2006
WHAT'S YOUR STATE DOING? PANDEMICFLU WEBSITE POSTS COMPREHENSIVE ARRAY OF
STATE PANDEMIC PLANNING INFORMATION
The federal government's PandemicFlu website (http://www.pandemicflu.gov)
recently added a new feature to its homepage. Titled Where You Live, it is a
multi-colored map of the United States. Under the map is this explanation:
"Selecting this map will take you to a page with links to state pandemic
planning information, state pandemic Web site information, and local state
contacts."
Click anywhere on the map to be taken to a larger map. Click on a state on
the larger map to be taken to a page of links pertinent to the state and its
pandemic planning information.
Back to
top |
| |
|
|
9. |
October 16, 2006
NEW STATE REQUIREMENTS: GOVERNORS OF KANSAS, LOUISIANA, AND NEW YORK SIGN
IMMUNIZATION LEGISLATION
The governors of Kansas and Louisiana recently signed legislation requiring
college and university students to show proof of vaccination against
meningococcal disease. The governor of New York signed a bill that expands
requirements for protecting children attending daycare facilities against
pneumococcal disease. Details follow.
MENINGOCOCCAL VACCINATION
Kansas. The governor signed a bill on April 14 that requires all incoming
college and university students who will be residing in student housing to
show proof of vaccination against meningococcal disease. The law allows for
waivers for students who refuse to be vaccinated. The requirement will become
effective July 1, 2007.
Louisiana. The governor signed a bill on June 8 that requires all students
taking courses on campus in public or nonpublic colleges and universities to
show proof of vaccination against meningococcal disease. Waivers are
permitted for students who choose not to be vaccinated. The law also requires
the educational institution to provide detailed information on the vaccine
and meningococcal disease to all students. The requirements became effective
for the fall 2006 school year.
Immunization Action Coalition has compiled information about all states that
have meningococcal prevention mandates for college and university students.
To access the information, go to:
http://www.immunize.org/laws/menin.htm
This information is also depicted visually on a map of the United States. To
access the map, go to:
http://www.immunize.org/laws/meninmap.pdf
PNEUMOCOCCAL VACCINATION
New York. The governor signed a bill into law on July 26 that expands the
immunization requirements for children attending childcare facilities,
effective immediately. The newest requirements are for age-appropriate
vaccination against pneumococcal disease and will apply to children born on
or after January 1, 2008.
Immunization Action Coalition has compiled information about all states that
have pneumococcal prevention mandates for children attending daycare. To
access the information, go to:
http://www.immunize.org/laws/pneuconj.htm
This information is also depicted visually on a map of the United States. To
access the map, go to:
http://www.immunize.org/laws/pneuconjmap.pdf
IAC depends on readers to help us stay informed and ensure our website
contains the most current and accurate information available. Please let us
know when any changes occur in your state by emailing us at
admin@immunize.org
Back to
top |
| |
|
|
10. |
October 16, 2006
CDC PUBLISHES UPDATE ON VACCINE-DERIVED POLIOVIRUSES WORLDWIDE
CDC published "Update on Vaccine-Derived Poliovirus" in the October 13 issue
of MMWR. Portions of a summary made available to the press are reprinted
below.
***********************
The oral poliovirus vaccine (OPV) is the primary tool used to eradicate polio
worldwide. Two primary categories of vaccine-derived polioviruses (VDPVs)
resembling wild polioviruses have been identified. Both of these VDPVs are
rare. Since 1961 only 30 of these VDPVs have been recognized and only eight
outbreaks have been identified in the past. Most iVDPV
[immunodeficiency-associated VDPV] infections cease spontaneously, and all
cVDPV [circulating VDPV] outbreaks have been rapidly controlled by OPV
campaigns. Sensitive laboratory methods have also been developed to support
global surveillance for VDPVs. The potential for VDPV emergence will continue
as long as OPV is used. Therefore, continued development and implementation
of a comprehensive strategy to minimize the risks of VDPV emergence through
high polio vaccine coverage remains a high priority.
***********************
To access a web-text (HTML) version of the complete article, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5540a3.htm
To access a ready-to-print (PDF) version of this issue of MMWR, go to:
http://www.cdc.gov/mmwr/PDF/wk/mm5540.pdf
Back to
top |
| |
|
|
11. |
October 16, 2006
MMWR ISSUES CORRECTION TO ITS OCTOBER 6 REPORT ON 2004-05 CHILDHOOD INFLUENZA
VACCINATION COVERAGE
CDC published "Erratum: Vol. 55, No. 39" in the October 13 issue of MMWR. The
correction is reprinted in its entirety, excluding references.
***********************
In the MMWR report, "Childhood Influenza Vaccination Coverage—United States,
2004-05 Influenza Season," on page 1061, an error occurred in the fifth
sentence of the first paragraph. The sentence should read, "Others
recommended to receive influenza vaccination include children aged 5-18 years
who have certain high-risk medical conditions, are on chronic aspirin
therapy, or who are household contacts of persons at high risk for influenza
complications."
***********************
To access a web-text (HTML) version of the complete article, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5540a8.htm
To access a ready-to-print (PDF) version of this issue of MMWR, go to:
http://www.cdc.gov/mmwr/PDF/wk/mm5540.pdf
Back to
top |
|
